论文部分内容阅读
目的:探讨和分析沙丁胺醇联合氨溴索治疗慢性阻塞性肺疾病的临床效果,总结其临床价值。方法:回顾性分析具有完整临床资料的2009年10月至2011年10月来我院就诊的慢性阻塞性肺疾病患者40例,随机分为观察组和对照组两组,每组患者有20例。两组患者均进行抗感染治疗,并给予吸氧、止咳化痰、平喘、维持水和酸碱电解质平衡治疗,对照组给予氨溴索静脉滴注治疗,观察组在对照组治疗的基础上雾化吸入沙丁胺醇进行治疗,观察和比较两组不同治疗方法的临床疗效。结果:按制定的标准评价治疗慢性阻塞性肺疾病的临床疗效。对照组总有效率为70.00%。观察组总有效率为90.00%。经X2检验,两组疗效具有显著性差异(P<0.05),观察组疗效优于对照组。结论:沙丁胺醇联合氨溴索治疗慢性阻塞性肺疾病具有较好的临床疗效,具有较好的临床价值,值得临床借鉴和推广。
Objective: To investigate and analyze the clinical effect of albuterol combined with ambroxol on chronic obstructive pulmonary disease (COPD) and summarize its clinical value. Methods: A retrospective analysis of 40 patients with chronic obstructive pulmonary disease who came to our hospital from October 2009 to October 2011 with complete clinical data was randomly divided into observation group and control group, with 20 patients in each group . Two groups of patients were anti-infective treatment, and give oxygen, cough and phlegm, asthma, water and acid-base balance to maintain the balance of treatment, control group given intravenous infusion of ambroxol, the observation group in the control group based on the treatment Inhalation of salbutamol inhalation treatment, observation and comparison of two groups of different treatment methods of clinical efficacy. Results: The clinical efficacy of the treatment of chronic obstructive pulmonary disease was evaluated according to the established standards. The total effective rate of the control group was 70.00%. The total effective rate of observation group was 90.00%. The X2 test showed significant difference between the two groups (P <0.05), the observation group was better than the control group. Conclusion: Salbutamol combined with ambroxol in the treatment of chronic obstructive pulmonary disease has good clinical efficacy, has good clinical value, it is worth clinical reference and promotion.